BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 24018986)

  • 1. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Boot E; Butcher NJ; Udow S; Marras C; Mok KY; Kaneko S; Barrett MJ; Prontera P; Berman BD; Masellis M; Dufournet B; Nguyen K; Charles P; Mutez E; Danaila T; Jacquette A; Colin O; Drapier S; Borg M; Fiksinski AM; Vergaelen E; Swillen A; Vogels A; Plate A; Perandones C; Gasser T; Clerinx K; Bourdain F; Mills K; Williams NM; Wood NW; Booij J; Lang AE; Bassett AS;
    Neurology; 2018 Jun; 90(23):e2059-e2067. PubMed ID: 29752303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
    Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
    Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.
    Gudbrandsen M; Bletsch A; Mann C; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
    Mol Autism; 2020 Jun; 11(1):46. PubMed ID: 32513259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 22q11.2 Deletion Syndrome-Associated Parkinson's Disease.
    Boot E; Bassett AS; Marras C
    Mov Disord Clin Pract; 2019 Jan; 6(1):11-16. PubMed ID: 30746410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 22q11.2 deletion syndrome in the relationship between congenital heart disease and scoliosis.
    Homans JF; de Reuver S; Heung T; Silversides CK; Oechslin EN; Houben ML; McDonald-McGinn DM; Kruyt MC; Castelein RM; Bassett AS
    Spine J; 2020 Jun; 20(6):956-963. PubMed ID: 31958577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Related Parkinsonian Signs in Microdeletion 22q11.2.
    Boot E; Mentzel TQ; Palmer LD; van Harten PN; Marras C; Lang AE; Bassett AS
    Mov Disord; 2020 Jul; 35(7):1239-1245. PubMed ID: 32386091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.
    Zafarullah M; Angkustsiri K; Quach A; Yeo S; Durbin-Johnson BP; Bowling H; Tassone F
    Metabolomics; 2024 Feb; 20(2):31. PubMed ID: 38418685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
    Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
    Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Cortical Folding Associated with Autistic Symptoms in Carriers and Noncarriers of the 22q11.2 Microdeletion.
    Gudbrandsen M; Mann C; Bletsch A; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
    Cereb Cortex; 2020 Sep; 30(10):5281-5292. PubMed ID: 32420595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome.
    Gudbrandsen M; Daly E; Murphy CM; Wichers RH; Stoencheva V; Perry E; Andrews D; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
    Cereb Cortex; 2019 Jul; 29(8):3655-3665. PubMed ID: 30272146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.
    Boot E; Butcher NJ; van Amelsvoort TA; Lang AE; Marras C; Pondal M; Andrade DM; Fung WL; Bassett AS
    Am J Med Genet A; 2015 Mar; 167A(3):639-45. PubMed ID: 25684639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.
    McDonald-McGinn DM; Fahiminiya S; Revil T; Nowakowska BA; Suhl J; Bailey A; Mlynarski E; Lynch DR; Yan AC; Bilaniuk LT; Sullivan KE; Warren ST; Emanuel BS; Vermeesch JR; Zackai EH; Jerome-Majewska LA
    J Med Genet; 2013 Feb; 50(2):80-90. PubMed ID: 23231787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening.
    Wenger TL; Miller JS; DePolo LM; de Marchena AB; Clements CC; Emanuel BS; Zackai EH; McDonald-McGinn DM; Schultz RT
    Mol Autism; 2016; 7():27. PubMed ID: 27158440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome.
    Karas DJ; Costain G; Chow EW; Bassett AS
    J Intellect Disabil Res; 2014 Feb; 58(2):198-210. PubMed ID: 23106770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.